Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT06735612
What this trial is testing

Respiratory Syncytial Virus Infection In Exacerbations of Chronic Obstructive Pulmonary Diasease: The RECODE Study

Who this might be right for
Respiratory Synctial VirusCOPDChronic Obstructive Pulmonary Disease (COPD)+1 more
Fundacio Privada Mon Clinic Barcelona 716
Not applicableStudy completedNCT04288921
What this trial is testing

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Who this might be right for
Influenza, HumanRespiratory Syncytial Virus Infections
LumiraDx UK Limited 525
Early research (Phase 1)Ended earlyNCT02460016
What this trial is testing

AK0529 in Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 1
Early research (Phase 1)Study completedNCT01290419
What this trial is testing

Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine

Who this might be right for
Respiratory Syncytial Virus Infections
Novavax 150
Testing effectiveness (Phase 2)Ended earlyNCT03715023
What this trial is testing

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients

Who this might be right for
Respiratory Syncytial Virus Infections
Pulmocide Ltd 5
Large-scale testing (Phase 3)Study completedNCT01466062
What this trial is testing

Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie (prior sponsor, Abbott) 28
Testing effectiveness (Phase 2)Study completedNCT02873286
What this trial is testing

RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic 420
Early research (Phase 1)Study completedNCT02237209
What this trial is testing

Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 29
Early research (Phase 1)WithdrawnNCT01797419
What this trial is testing

Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus Infections
Gilead Sciences
Not applicableActive Not RecruitingNCT07816471
What this trial is testing

RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsImmunocompromised HostInfluenza+1 more
Hospital Italiano de Buenos Aires 350
Not applicableLooking for participantsNCT04743609
What this trial is testing

RSV Burden in Outpatient and Hospital Settings

Who this might be right for
RSV InfectionChildren, OnlyOutpatient+1 more
Association Clinique Thérapeutique Infantile du val de Marne 1,900
Large-scale testing (Phase 3)Ended earlyNCT00031473
What this trial is testing

Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT05900154
What this trial is testing

Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age

Who this might be right for
RESPIRATORY SYNCYTIAL VIRUS (RSV)
Pfizer 128
Not applicableStudy completedNCT05506670
What this trial is testing

Disease Burden of RSV

Who this might be right for
RSV Acute Respiratory Infection
Hospices Civils de Lyon 84
Early research (Phase 1)Study completedNCT01968083
What this trial is testing

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 51
Testing effectiveness (Phase 2)Ended earlyNCT03572062
What this trial is testing

Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Who this might be right for
Respiratory Tract Infection
Pfizer 317
Not applicableWithdrawnNCT01098227
What this trial is testing

Exhaled Nitric Oxide Levels in Infants and Young Children Infected With RSV or Other Viral Infections

Who this might be right for
BronchiolitisInfectionNitric Oxide
NYU Langone Health
Not applicableUnknownNCT05348655
What this trial is testing

Impact of the Covid-19 on RSV Epidemic in the Metropolis of Lyon

Who this might be right for
RhinovirusRSV Infection in Children Less Than 5 Years of Age
Hospices Civils de Lyon 600
Early research (Phase 1)Study completedNCT01905215
What this trial is testing

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 128
Not applicableStudy completedNCT07177508
What this trial is testing

First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Viral (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Prevention
Nicola Irwin 2,355
Next Page